526 related articles for article (PubMed ID: 29212815)
1. Rab29 activation of the Parkinson's disease-associated LRRK2 kinase.
Purlyte E; Dhekne HS; Sarhan AR; Gomez R; Lis P; Wightman M; Martinez TN; Tonelli F; Pfeffer SR; Alessi DR
EMBO J; 2018 Jan; 37(1):1-18. PubMed ID: 29212815
[TBL] [Abstract][Full Text] [Related]
2. Endogenous Rab29 does not impact basal or stimulated LRRK2 pathway activity.
Kalogeropulou AF; Freemantle JB; Lis P; Vides EG; Polinski NK; Alessi DR
Biochem J; 2020 Nov; 477(22):4397-4423. PubMed ID: 33135724
[TBL] [Abstract][Full Text] [Related]
3. LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network.
Liu Z; Bryant N; Kumaran R; Beilina A; Abeliovich A; Cookson MR; West AB
Hum Mol Genet; 2018 Jan; 27(2):385-395. PubMed ID: 29177506
[TBL] [Abstract][Full Text] [Related]
4. Endogenous Rab38 regulates LRRK2's membrane recruitment and substrate Rab phosphorylation in melanocytes.
Unapanta A; Shavarebi F; Porath J; Shen Y; Balen C; Nguyen A; Tseng J; Leong WS; Liu M; Lis P; Di Pietro SM; Hiniker A
J Biol Chem; 2023 Oct; 299(10):105192. PubMed ID: 37625589
[TBL] [Abstract][Full Text] [Related]
5. Development of phospho-specific Rab protein antibodies to monitor
Lis P; Burel S; Steger M; Mann M; Brown F; Diez F; Tonelli F; Holton JL; Ho PW; Ho SL; Chou MY; Polinski NK; Martinez TN; Davies P; Alessi DR
Biochem J; 2018 Jan; 475(1):1-22. PubMed ID: 29127256
[TBL] [Abstract][Full Text] [Related]
6. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.
Rivero-Ríos P; Romo-Lozano M; Fernández B; Fdez E; Hilfiker S
Cells; 2020 Jul; 9(7):. PubMed ID: 32709066
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
[TBL] [Abstract][Full Text] [Related]
8. Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases.
Gomez RC; Wawro P; Lis P; Alessi DR; Pfeffer SR
J Cell Biol; 2019 Dec; 218(12):4157-4170. PubMed ID: 31624137
[TBL] [Abstract][Full Text] [Related]
9. Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.
Nirujogi RS; Tonelli F; Taylor M; Lis P; Zimprich A; Sammler E; Alessi DR
Biochem J; 2021 Jan; 478(2):299-326. PubMed ID: 33367571
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms.
Malik AU; Karapetsas A; Nirujogi RS; Mathea S; Chatterjee D; Pal P; Lis P; Taylor M; Purlyte E; Gourlay R; Dorward M; Weidlich S; Toth R; Polinski NK; Knapp S; Tonelli F; Alessi DR
Biochem J; 2021 Feb; 478(3):553-578. PubMed ID: 33459343
[TBL] [Abstract][Full Text] [Related]
11. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
12. A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation.
Vides EG; Adhikari A; Chiang CY; Lis P; Purlyte E; Limouse C; Shumate JL; Spínola-Lasso E; Dhekne HS; Alessi DR; Pfeffer SR
Elife; 2022 Sep; 11():. PubMed ID: 36149401
[TBL] [Abstract][Full Text] [Related]
13. Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitors.
Ito G; Katsemonova K; Tonelli F; Lis P; Baptista MA; Shpiro N; Duddy G; Wilson S; Ho PW; Ho SL; Reith AD; Alessi DR
Biochem J; 2016 Sep; 473(17):2671-85. PubMed ID: 27474410
[TBL] [Abstract][Full Text] [Related]
14. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis.
Steger M; Diez F; Dhekne HS; Lis P; Nirujogi RS; Karayel O; Tonelli F; Martinez TN; Lorentzen E; Pfeffer SR; Alessi DR; Mann M
Elife; 2017 Nov; 6():. PubMed ID: 29125462
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of Rab29 at Ser185 regulates its localization and role in the lysosomal stress response in concert with LRRK2.
Komori T; Kuwahara T; Fujimoto T; Sakurai M; Koyama-Honda I; Fukuda M; Iwatsubo T
J Cell Sci; 2023 Jul; 136(14):. PubMed ID: 37365944
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide screen reveals Rab12 GTPase as a critical activator of Parkinson's disease-linked LRRK2 kinase.
Dhekne HS; Tonelli F; Yeshaw WM; Chiang CY; Limouse C; Jaimon E; Purlyte E; Alessi DR; Pfeffer SR
Elife; 2023 Oct; 12():. PubMed ID: 37874635
[TBL] [Abstract][Full Text] [Related]
17. Impact of Type II LRRK2 inhibitors on signaling and mitophagy.
Tasegian A; Singh F; Ganley IG; Reith AD; Alessi DR
Biochem J; 2021 Oct; 478(19):3555-3573. PubMed ID: 34515301
[TBL] [Abstract][Full Text] [Related]
18. Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2.
Zhu H; Tonelli F; Turk M; Prescott A; Alessi DR; Sun J
Science; 2023 Dec; 382(6677):1404-1411. PubMed ID: 38127736
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization.
Nichols RJ; Dzamko N; Morrice NA; Campbell DG; Deak M; Ordureau A; Macartney T; Tong Y; Shen J; Prescott AR; Alessi DR
Biochem J; 2010 Sep; 430(3):393-404. PubMed ID: 20642453
[TBL] [Abstract][Full Text] [Related]
20. Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation.
Kuwahara T; Funakawa K; Komori T; Sakurai M; Yoshii G; Eguchi T; Fukuda M; Iwatsubo T
Neurobiol Dis; 2020 Nov; 145():105081. PubMed ID: 32919031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
